8 VCs and 1 funds investing in Data Science
Partner
Khosla Ventures
Check: No personal check range is published. Khosla's Seed Fund supports science and business-model experiments, historically often with roughly $1M–$2M according to a 2020 firm interview, while its Main Fund covers early through later stages. These are firm-level references, not Alex's authority.
Alex invests where computation, biology, and healthcare converge. His scientific and clinical background supports a systems view of biomarker discovery, therapeutics, diagnostics, personalized medicine, neurotechnology, connected devices, and AI-enabled care. He favors important health outcomes and technologies that can automate expensive or inconsistent processes, increase access, and create reproducible, lower-cost care—not science detached from delivery and economics.
Managing Partner
Good Growth Capital
Check: The firm does not publish a person-specific check-size range on its current official website.
Maureen Stancik Boyce, PhD is part of Good Growth Capital's current team. No narrower person-specific mandate is published, so this profile uses the firm's official strategy: Identify hidden early potential in life sciences, data science, green technology, advanced materials, and other technically defensible innovations.
Managing Partner
Good Growth Capital
Check: The firm does not publish a person-specific check-size range on its current official website.
Amy Salzhauer is part of Good Growth Capital's current team. No narrower person-specific mandate is published, so this profile uses the firm's official strategy: Identify hidden early potential in life sciences, data science, green technology, advanced materials, and other technically defensible innovations.
Managing Partner
Good Growth Capital
Check: The firm does not publish a person-specific check-size range on its current official website.
Carolyne LaSala is part of Good Growth Capital's current team. No narrower person-specific mandate is published, so this profile uses the firm's official strategy: Identify hidden early potential in life sciences, data science, green technology, advanced materials, and other technically defensible innovations.
Managing Partner
Good Growth Capital
Check: The firm does not publish a person-specific check-size range on its current official website.
David Mendez is part of Good Growth Capital's current team. No narrower person-specific mandate is published, so this profile uses the firm's official strategy: Identify hidden early potential in life sciences, data science, green technology, advanced materials, and other technically defensible innovations.
Principal
Good Growth Capital
Check: The firm does not publish a person-specific check-size range on its current official website.
Sophie Hagerty is part of Good Growth Capital's current team. No narrower person-specific mandate is published, so this profile uses the firm's official strategy: Identify hidden early potential in life sciences, data science, green technology, advanced materials, and other technically defensible innovations.
Principal
Good Growth Capital
Check: The firm does not publish a person-specific check-size range on its current official website.
Aditi Rajagopal is part of Good Growth Capital's current team. No narrower person-specific mandate is published, so this profile uses the firm's official strategy: Identify hidden early potential in life sciences, data science, green technology, advanced materials, and other technically defensible innovations.
Associate
Good Growth Capital
Check: The firm does not publish a person-specific check-size range on its current official website.
Ziad Sarby is part of Good Growth Capital's current team. No narrower person-specific mandate is published, so this profile uses the firm's official strategy: Identify hidden early potential in life sciences, data science, green technology, advanced materials, and other technically defensible innovations.